 |
efaproxiral |
|---|---|
| Trade Name | |
| Orphan Indication | Adjunct to whole brain radiation therapy for the treatment of brain metastases in patients with breast cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-07-28 00:00:00 |
| Sponsor | Allos Therapeutics, Inc.;11080 CirclePoint Road, Suite 200;Westminster, Colorado, 80020 |
